The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| KNE | -68.18% | -72% | -22.47% | -98% |
| S&P | +12.9% | +73.65% | +11.66% | +643% |
Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. It operates through Domestic and International geographical segments. The firm's trademarks include StrixNB, DispersinB, Aledex, bluestem, silkstem, coactiv+, and Kan. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
No news articles found for Kane Biotech.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $8.50K | -99.3% |
| Gross Profit | -$41.35K | -108.1% |
| Gross Margin | -486.50% | -526.4% |
| Market Cap | $7.48M | -59.7% |
| Net Income | -$607.35K | 10.5% |
| EBITDA | -$507.21K | 23.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $939.06K | 72.5% |
| Accounts Receivable | $131.15K | -61.8% |
| Inventory | 0.3 | -50.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.68M | -8.6% |
| Short Term Debt | $621.55K | 38.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -58.59% | 0.0% |
| Return On Invested Capital | -571.76% | -731.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$698.22K | -28.6% |
| Operating Free Cash Flow | -$698.22K | -29.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -21.96 | -18.96 | -6.82 | -31.69 | 23.36% |
| Price to Sales | 7.28 | 5.84 | 4.41 | 13.10 | - |
| Price to Tangible Book Value | -10.68 | -9.23 | -4.57 | -9.27 | -27.46% |
| Enterprise Value to EBITDA | -16.33 | -12.97 | -33.42 | -17.53 | -43.13% |
| Total Debt | $2.18M | $2.06M | $2.59M | $2.30M | 0.66% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
